七月 2026
- Home
- Cambridge Technologies
七月 2026的Cambridge Technologies市场份额分析
As new diseases emerge and pathogenic organisms adapt to the environment, we are working on products that can be used to help you respond to the new challenges in bovine health. For a list of diseases we are typically dealing with click here.
Cambridge Technologies(包含公司地区分支机构)
查看更多网站流量和参与度信息- cambridgetechnologies.com
Cambridge Technologies收入截至 七月 2026为 10M - 15M
Cambridge Technologies主要域名产生的收入
3 年中Cambridge Technologies主要域名的收入
Cambridge Technologies主要域名的收入
Cambridge Technologies热门域名的总访问量
了解Cambridge Technologies市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Cambridge Technologies热门域名的平均访问时长
分析Cambridge Technologies参与度指标。
过去 3 个月的平均访问时长
子公司明细
Cambridge Technologies热门域名的平均页面浏览量
了解Cambridge Technologies如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Cambridge Technologies 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Merck & Co. partnered with Cambridgetechnologies on Apr 1st '24.RAHWAY, N.J. - Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has entered into an agreement with Cambridge Technologies, an independent custom vaccine company based in Worthington, Minn., to sell and market its innovative autogenous poultry vaccines in the United States.
四月 1, 2024阅读更多
新闻Merck Animal Health USA partners with Cambridgetechnologies.Merck Animal Health announces an agreement with Cambridge Technologies to provide autogenous vaccines to the U.S. Poultry industry.
四月 1, 2024阅读更多
新闻Cambridgetechnologies is developing custom vaccine solutions.Cambridge Technologies uses cutting-edge molecular diagnostic and manufacturing techniques to develop custom vaccine solutions to help veterinarians and poultry producers manage emerging disease challenges.
三月 31, 2024阅读更多
查看 Cambridge Technologies 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
